(Total Views: 127)
Posted On: 03/06/2017 8:41:55 PM
Post# of 98225
$RSII READ CLOSELY, MARIJUANA Pharmaceutical stock in the MMJ compounding industry.
"I feel that Rising BioSciences will deliver shareholder value in a big way," states DiPrima. "There are ample prospects within the MMJ R&D markets, particularly those budding in the pharmaceutical compounding sector. Rising BioSciences seeks to fulfill a yet-to-be-met market demand with a first to market approach so that patients across the U.S. get the treatment they so desperately need without falling subject to the dangers of opiates, whose long-term effects can include liver damage, dependence/addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications."
patients ACROSS the U.S.
This is going to be unreal with Management Ties!!
"I feel that Rising BioSciences will deliver shareholder value in a big way," states DiPrima. "There are ample prospects within the MMJ R&D markets, particularly those budding in the pharmaceutical compounding sector. Rising BioSciences seeks to fulfill a yet-to-be-met market demand with a first to market approach so that patients across the U.S. get the treatment they so desperately need without falling subject to the dangers of opiates, whose long-term effects can include liver damage, dependence/addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications."
patients ACROSS the U.S.
This is going to be unreal with Management Ties!!
(0)
(0)Scroll down for more posts ▼
